ALL YOU NEED FOR A NEEDLE-FREE

INTRADERMAL FUTURE

USE THE MENU BUTTONS TO NAVIGATE THROUGH THE DOCUMENT

ContentsNeedle tip deterioration

Why needle-free

Needle-free / intradermal benefits

The perfect match

Needle-free improves welfare

Why intradermal?

The way it works

How vaccine is deposited in the pig

Reduction of skin lesions and stress

IDAL® 3G device

Porcilis® intradermal portfolio

References

Needle-free and intradermal: the perfect matchNeedle-free and intradermal application of vaccines is the most advanced method for vaccinating pigs today.

The ergonomically designed, reliable and easy-to-use IDAL® device makes vaccination safe and less stressful for people and pigs, while ensuring efficacy at the same time.

Together with the broadest range of specifically formulated intradermal vaccines – Porcilis® PCV ID, Porcilis® M Hyo ID ONCE, Porcilis® PRRS, Prime Pac® PRRS and Porcilis® Begonia IDAL – The IDAL® Way is an important step forward in controlling major diseases affecting pig operations worldwide.

INTRADERMAL BENEFITS

QUALITYLess risks for muscle damage.

EFFICACYQuick, effective immune response2, 5, 6 (at least as good as with IM vaccination).

Antigen-presenting cells in the epidermis induce a broad range of immune responses.5, 6

Pre-existing immunity may be overcome since (maternal) antibodies are not located in the skin.

FOOD SAFETYThe injected volume is only 10-20% of the total volume of an intramuscular vaccine dose and the distribution of the vaccine is limited to the skin.

SAFETYFewer adverse systemic events.1, 2

USER SAFETYNeedle-free vaccination reduces the risk of self-injection.

WELFAREMuch less pain and stress for the pigs being vaccinated.4

ANIMAL SAFETYNo accidental iatrogenic transmission of pathogens from reusing needles (such as PRRS).1

QUALITYPotential tissue damage is reduced and there is no risk of needle pieces remaining in the meat due to broken needles.1

NEEDLE-FREE BENEFITS

Why needle-free vaccination delivers instant benefitsTraditional intramuscular vaccination with a needle and syringe has many disadvantages for pigs and administrators. Needle injections result in stress and pain in pigs and increase the risk for transmitting disease. In addition, accidental needle sticks, disposal of used needles and broken needles are a problem for administrator and consumers.

Needle-free vaccination is a great alternative for pigs and administrator. Needle-free devices deposit the exact vaccine dose through the skin under high pressure and in a fraction of a second, resulting in less stress on the pigs and easier vaccination routine for the administrator.

Multiple needle injections negatively impact needle quality3

USED ONCEBRAND NEW NEEDLE USED X12

Needle becomes dull, even after just one injection.

Tip is forming a barbed hook.

Needle becomes more dull.

Biological matter (Blood cells, bacteria, etc.).

Even more biological matter (Blood cells, bacteria, etc.).

Vaccinating needle-free improves the welfare of both sows and piglets4

• No needles, and a vaccination volume of only 0.2 ml, mean no pain and less stress for the pigs.

• Studies show that fear and pain indicators at time of injection are reduced.• Fear response to assessor increased in IM group 24 h post-vaccination.• General activity decreased in IM sows vs IDAL® (p<0,05).• No differences in social behavior, exploration, drinking, resting patterns.

0.0%

10.0%

20.0%

30.0%

40.0%

50.0%

60.0%

70.0%

80.0%

90.0%

100.0%

IDAL® group IDAL® group IDAL® groupControl groupDay before vaccination

* Indicates a signi�cant difference between IDAL® group and control group (p<0.05).

Resting

Day of vaccination Day after vaccinationControl group Control group

Standing Moving Suckling Socializing

* * * * * * * * * * * * * * * * * *0.0%

10.0%

20.0%

30.0%

40.0%

50.0%

60.0%

70.0%

80.0%

90.0%

100.0%

High pitchvocalizations

Retreatattempts

Turningback

Change inbehaviour

IDAL® IM

0.0%

10.0%

20.0%

30.0%

40.0%

IDAL® IM

PIGLET STUDY — BEHAVIORAL RESULTS IN PIGLETSSOW STUDY — BEHAVIORAL PARAMETERS SOW STUDY — PANIC RESPONSE TO OBSERVER 24 HOUR POST-VACCINATION

Why intradermal vaccination stimulates an effective immune responseCompared to intramuscular (IM) administration, vaccination into the dermis is advantageous because high concentrations of powerful, specialized cells located in the skin respond very quickly and efficiently to vaccine antigens. Intradermal vaccination stimulates an immune response as efficient or better as following IM administration.2, 5, 6

I II Vaccine antigens are administered intradermal using the IDAL® device.

III Dendritic cells are activated in order to capture and process the antigens, carrying important information to the nearest skin-draining lymph node.5, 6

IV V Once in the lymph node, dendritic cells present antigen materials to naive T lymphocytes and B lymphocytes found within the lymph node. Now activated, these cells stimulate a direct and strong immune response to the antigen so the pig can start building immunity against future infections. Cytotoxic T lymphocytes destroy virus-infected cells and provide cell-mediated immunity. Helper T lymphocytes help transform B lymphocytes into Plasma B lymphocytes, which produce specific antibodies and also provide humoral immunity.

I IIIII IV V

Epidermis

Dermis

Vein

Antigens

Dendritic cells

Skin-draining lymph node

Activated dendritic cells

Naive T lymphocytes

Naive B lymphocytes

Helper T lymphocytes

Cytotoxic T lymphocytes

Plasma B lymphocytes

Antibodies

How vaccine is deposited in the pig3

VACCINE PRESENCE IN THE PIG

DEPTH LATERAL SPREAD

COMMENT

IDAL® Extends to 12 mm below skin

18-22 mm Cloud and line like appearance indicative of fine and lateral vaccine dispersion

IM Starts at 12 mm and extends to 34 mm

38-48 mm Bolus/depot of vaccine in deeper next region surrounding vertebrae

INTRAMUSCULARTHE IDAL® WAY

THE IDAL® WAYINTRAMUSCULAR

Study demonstrates that the IDAL® device disperses the vaccine in the dermis layers, resulting in greater exposure to the immune system.

Reduction of skin lesions and stress4

0

10

20

30

40

IDAL®. n = 15CRP

µg/m

L

IM. n = 13

* p-value = 0.064

0

1

0.8

0.6

0.4

0.2

Vaccination

Chromogranin-A

µg/m

L

IDAL®. n = 23 IM. n = 21

REDUCTION OF MUSCULAR LESIONS IN SOWS VACCINATED INTRADERMALLY

REDUCTION OF STRESS INDICATOR IN SOWS VACCINATED INTRADERMALLY

PERCENTAGE REDUCTION OF ANIMALS WITH INFLAMMATION/SKIN DISCOLORATION WHEN VACCINATED INTRADERMALLY

+28 HOURS +52 HOURS +7 DAYS +28 DAYS

IDAL® 47%* 53% 5% 0%

IM 9% 22% 22% 26%**

* **

Needle-free vaccination reduces sow’s fear and pain reaction to the vaccination procedure compared to vaccination with a needle-syringe. The absence of any skin reaction at the injection site 28 days post-vaccination and lower CRP levels in needle-free sows compared to needle-syringe sows supports that needle-free vaccination may prevent the acute phase response and long term muscular damage associated with an injection. Needle-free vaccination is therefore a promising alternative for improving the welfare of gestating sows.

TRACEABILITY• Connected by Bluetooth to a supporting

smartphone app.• Enhances record keeping and traceability.

IDAL® 3GDesigned for safe and efficient vaccination

CONVENIENCE• Large numbers of pigs can be

vaccinated at once reducing labour and increasing efficiency.

• Easy maintenance and cleaning before/after each session.

• Long-lasting batteries.• Multiple injection site locations.• Safety features included.

COMPLIANCE• Scientifically proven efficacy and safety.• Ensures the proper dose every time.• Alerts when the vaccine vial is empty.

Porcilis® intradermal vaccine portfolio for needle-free administration

One-dose vaccine for immunization of piglets as early as 3 weeks of age to reduce lung lesions and decrease in daily weight gain during the finishing period following a Mycoplasma hyopneumoniae infection.

Modified live vaccine for immunization of pigs as early as 2 weeks of age against PRRSv-2.

Live, attenuated vaccine for the immunization of pigs against Aujeszky’s disease virus (Pseudorabies) infections.

Modified live vaccine for the immunization of pigs against PRRSv throughout the production system from as early as 2 weeks of age.

The first intradermal PCV vaccine for active immunization of pigs as early as 3 weeks of age. Vaccination reduces PCV2 viremia, viral load in lung and lymphoid tissue, and virus shedding. In addiition, loss of daily weight gain and mortality associated with a PCV2 infection are also reduced. Duration of immunity is 23 weeks following vaccination.

1

Chase C.C.L., Daniels C.S., Garcia R., Milward F. and Nation T. Needle-free injection technology in swine: Progress toward vaccine efficacy and pork quality. J Swine Health Prod. 2008;16(5):254-261.

2

Summerfield A. The dermis as a prime site of vaccine delivery. International Pig Topics. October 2014.

3

J. Kauffold & H. Sigmarsson, Large Animal Clinic for Theriogenology and Ambulatory Services; E. Ludewig & M. Alef, Clinic for for Small Animals, Faculty of Veterinary Medicine, University of Leipzig, Germany. Images courtesy of University of Veterinary Medicine Giessen, Germany in Cooperation with MSD Animal Health, Germany.

4

Temple D., Mainau E., Amat M. and Manteca X. Animal welfare benefits of the intradermal vaccination in pregnant sows. Porcine Health Management (2017) 3:9.

5

Romani N., Flacher V., Tripp C., Sparber F., Ebner S. and Stoitzner P. Targeting Skin Dendritic Cells to Improve Intradermal Vaccination. Current Topics in Microbiology and Immunology, 2012. 351: 113-138.

6

Teunissen M., Haniffa M. and Collin M. Insight into the immunobiol-ogy of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design. Current Topics in Microbiology and Immunology, 2012. 351: 25-76.

References

© 2017 Intervet International B.V., also known as MSD Animal Health. All rights reserved. MSD Animal Health. P.O. Box 31, 5830 AA Boxmeer, The Netherlands. GL/IDA/0318/0008a